Gilead Submits Expanded Application For Yescarta Cancer Treatment
Trump Vaccine Czar Says COVID-19 Vaccine By Election Day "Very, Very Unlikely"
What Pac-12’s New Rapid COVID-19 Tests Mean for Sports Return
AMA Joins Law Suit Targeting “Menthol Slavery”
Vertex and Covid-19 spell the end for Savara's CF program
Is Trevena Stock a Buy Right Now? This Is What You Need to Know
Compass plans $100m IPO to fund magic mushroom depression drug
How to Stymie Distribution of a Potentially Dangerous Vaccine
Too Little is not Enough
Innovative biocontainment unit shows promise to protect healthcare workers
COVID-19 vaccine could be ready in time for US elections
S&P Futures Inexplicably Dip As "Magical, Non-Stop Rally" Reverses
Abbot Labs: New COVID-19 Antibody Test Is a Game Changer, Says Analyst
Vanderbilt launches clinical trial of outpatient treatments for COVID-19
A ‘Human’ Touch vs. COVID-19
Novavax Strikes Covid-19 Vaccine Deal With Canada As Investors Take Profits
Mesoblast's Late-Stage Covid-19 Trial Secures Ethics Approval In Australia
Lancet Study Finds US Has, By Far, The World’s Most Overpriced Medical Care
Bristol Myers Scores FDA Nod For Acute Myeloid Leukemia Treatment
US Close- Another Mega-cap tech rally, Oil stronger, Gold can’t hold $2000
NIH Attacks FDA Over 'Premature' Approval Of 'Trump-Backed' Convalescent Plasma
Tuesday's Market Snapshot: Here's What You Need To Know Right Now
Medical Groups Can Fight Possibly Deadly COVID-19 Vaccine
Oxford Biomedica, AstraZeneca Expand Covid-19 Vaccine Supply Deal
Athenex Spikes 12% On FDA Application For Oral Breast Cancer Treatment
Sanofi Says Kevzara Drug Fails To Meet Endpoints in Covid-19 Study
Will the new 15-minute COVID-19 test solve US testing problems?
WHO's Tedros Warns "No Country Can Just Pretend The Pandemic Is Over" As Trump Embraces 'Herd Immunity'
Genetic Engineering, No Virus Required
A history of the pharmaceutical industry